Literature DB >> 944059

Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.

A L Jaton, D M Loew, J M Vigouret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 944059      PMCID： PMC1666968     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  Stereotypic and anticataleptic activities of amphetamine after intracerebral injections.

Authors:  B Costall; R J Naylor; J E Olley
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

2.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

Authors:  U Ungerstedt; G W Arbuthnott
Journal:  Brain Res       Date:  1970-12-18       Impact factor: 3.252
  2 in total
  4 in total

1.  Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat.

Authors:  H R Bürki; H Asper; W Ruch; P E Züger
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

2.  Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].

Authors:  A L Jaton; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

3.  Treatment of Schizophrenia with ergot derivatives.

Authors:  C A Tamminga; M H Schaffer
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

4.  Dopamine agonists and cobalt-induced epilepsy in the rat.

Authors:  I B Farjo; J K McQueen
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.